PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29374730
OWN - NLM
STAT- In-Process
LR  - 20180201
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 2
DP  - 2018 Feb
TI  - Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial 
      Clinical Experience and Validation of Clinical Staging.
PG  - 979-986
AB  - AIM: To evaluate the clinical results of two-step intensity-modulated radiation
      therapy (IMRT) for oropharyngeal cancer. PATIENTS AND METHODS: Eighty patients
      were treated with two-step IMRT between 2002 and 2014. Whole-neck radiotherapy
      (44.0-50.0 Gy/22-25 fractions) was delivered by IMRT, followed by boost IMRT to
      the high-risk clinical target volume (total dose of 70.0 Gy/35 fractions).
      Forty-seven patients received concurrent chemotherapy. Immunohistochemistry for
      human papillomavirus type 16 (HPV/p16) was performed for 64 patients. RESULTS:
      The 5-year overall survival and locoregional control rates for stage I, II, III, 
      and IVA-B disease were 80.0%, 75.0%, 78.0%, and 64.0% and 100.0%, 75.0%, 92.0%,
      and 82.0%, respectively. Overall survival was significantly higher in
      HPV/p16-positive patients than in HPV/p16-negative patients (p=0.01). Xerostomia 
      of grade 2 or more was noted in 10 patients. CONCLUSION: Favourable overall
      survival and locoregional control rates with excellent salivary preservation were
      obtained using the two-step IMRT method for oropharyngeal cancer.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Tatebe, Hitoshi
AU  - Tatebe H
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan [email protected]
FAU - Doi, Hiroshi
AU  - Doi H
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Ishikawa, Kazuki
AU  - Ishikawa K
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Kawakami, Hisato
AU  - Kawakami H
AD  - Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Yokokawa, Masaki
AU  - Yokokawa M
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Nakamatsu, Kiyoshi
AU  - Nakamatsu K
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Kanamori, Shuichi
AU  - Kanamori S
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
FAU - Shibata, Toru
AU  - Shibata T
AD  - Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
FAU - Kitano, Mutsukazu
AU  - Kitano M
AD  - Department of Otorhinolaryngology, Kindai University Faculty of Medicine, Osaka, 
      Japan.
FAU - Nishimura, Yasumasa
AU  - Nishimura Y
AD  - Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka,
      Japan.
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
OTO - NOTNLM
OT  - *Human papillomavirus
OT  - *intensity-modulated radiation therapy
OT  - *locoregional control
OT  - *oropharyngeal cancer
OT  - *overall survival
OT  - *radiation therapy
EDAT- 2018/01/29 06:00
MHDA- 2018/01/29 06:00
CRDT- 2018/01/29 06:00
PHST- 2017/11/02 00:00 [received]
PHST- 2017/11/27 00:00 [revised]
PHST- 2017/11/28 00:00 [accepted]
PHST- 2018/01/29 06:00 [entrez]
PHST- 2018/01/29 06:00 [pubmed]
PHST- 2018/01/29 06:00 [medline]
AID - 38/2/979 [pii]
AID - 10.21873/anticanres.12312 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 Feb;38(2):979-986. doi: 10.21873/anticanres.12312.